TY  - JOUR
AU  - Sánchez‐Arévalo Lobo, Víctor J.
AU  - Cuesta Martínez, Ángel
AU  - Sanz, Laura
AU  - Compte, Marta
AU  - García, Pascal
AU  - Prieto, Jesús
AU  - Blanco, Francisco J.
AU  - Álvarez‐Vallina, Luis
PY  - 2006
DO  - 10.1002/ijc.21851
SN  - 0020-7136
SN  - 1097-0215
UR  - https://hdl.handle.net/20.500.14352/92808
T2  - International Journal of Cancer
AB  - Antiangiogenic therapy is nowadays one of the most active fields in cancer research. The first strategies, aimed at inhibiting tumor vascularization, included upregulation of endogenous inhibitors and blocking of the signals delivered by angiogenic...
LA  - eng
M2  - 455
PB  - Wiley
TI  - Enhanced antiangiogenic therapy with antibody‐collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events
TY  - journal article
VL  - 119
ER  -